HeartBeam, Inc. BEAT
0.40 USD 0.00 (+0.00%)
Regular-session close
0.38 -0.01 -3.59%
Pre-market · Nov 16, 9:15 AM ET
Day range unavailable
0.355 52-week range 4.00
- YTD
- -83.52%
- 1 year
- -74.81%
News
seekingalpha.com HeartBeam, Inc. (BEAT) Q3 2026 Earnings Call Transcript HeartBeam, Inc. (BEAT) Q3 2026 Earnings Call Transcriptbenzinga.com HeartBeam Q3 EPS $(0.05) Beats $(0.09) Estimate HeartBeam (NASDAQ:BEAT) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.09) by 44.44 percent. This is a 66.67 percent increase over losses of $(0.15)…
businesswire.com HeartBeam Reports Third Quarter 2026 Results SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Reports Third Quarter 2026 Results.benzinga.com HeartBeam Wins FDA Total Product Life Cycle Advisory Program Pilot Acceptance For Heart Attack Assessment Technology Acceptance into FDA’s TAP Pilot follows Breakthrough Device Designation granted earlier this month for HeartBeam’s heart attack assessment technologyTAP Pilot provides dedicated FDA advisors and…
benzinga.com HeartBeam Completes Enrollment Ahead Of Schedule In 486-Patient HEADSTART-ACS Study HEADSTART-ACS study conducted in collaboration with Indonesia’s National Cardiovascular Center in world’s fourth most populous country, representing strategically significant market of 288 million…
